Stocks Reverse Gains While Bond Yields Weigh On Tech

The major indexes are giving back this morning's gains as investors brush off upbeat jobs data and focus on the 10-year Treasury yield, which continues to weigh on the tech sector after earlier topping 1.6%. The Dow Jones Industrial Average (DJI) is down nearly 130 points midday. The S&P 500 Index (SPX) and the Nasdaq Composite (IXIC) are also swimming in red ink, with the latter headed for its worst week since 2008. The Dow and S&P 500 are on track for weekly losses as well.

Wall Street is also eyeing several Covid-19 updates. Dr. Anthony Fauci has chimed in on state reopenings, expressing concerns over a continued surge in the virus and encouraging slower reversals of Covid-19 measures. Plus, the Biden administration has announced two new vaccination sites in Cleveland, OH and Atlanta, GA -- both capable of managing 6,000 shots per day. 


One stock seeing a surge in bearish options activity today is StoneCo Ltd (Nasdaq: STNE). So far, 32,000 puts have crossed the tape, which is 14 times what's typically seen at this point. The weekly 3/12 85-strike put is the most popular, followed by the 3/5 85-strike put, with new positions being opened at the former. At last check, STNE is down 8.2% to trade at $70.85, despite a price-target hike from Susquehanna to $105 from $74. 

One stock surging higher on the New York Stock Exchange (NYSE) today is IMAX Corporation (NYSE: IMAX). The shares are up 9.6% to trade at $22.70 at last check, after the Canada-based movie theater company reported better-than-expected fourth-quarter revenue, despite slightly wider-than-expected losses per share. In response, Benchmark raised its price target to $24. Today's pop has IMAX at a fresh annual high, up 28% year-to-date.


Conversely, the shares of Medallia Inc (NYSE: MDLAare plummeting after its quarterly confessional. The equity is down 21% to trade at $29.75, after the company reported fourth-quarter losses of one cent per share -- in line with analyst estimates -- and better-than-expected revenue. Medallia's disappointing quarterly sales forecast is likely to blame for the steep pullback. Several analysts chimed in following the event. Stifel cut its price target by $2 to $40, while Craig-Hallum and Truist Securities raised theirs to $44 and $45, respectively. 

Disclaimer: Schaeffer's Investment Research ("SIR" or "we" or "us") is not registered as an investment adviser. SIR relies upon the "publishers' ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.